Simplex Trading’s Tarsus Pharmaceuticals TARS Stock Holding History

Simplex Trading’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-200	Closed	-$11K	–	10030
2025 Q3	$11K	Buy	+200	New	+$9.85K	﹤0.01%	7841
2025 Q1	–	Sell	-300	Closed	-$16K	–	9655
2024 Q4	$16K	Buy	+300	New	+$13.6K	﹤0.01%	6873
2024 Q3	–	Sell	-300	Closed	-$8K	–	9556
2024 Q2	$8K	Sell	300 -16,600	-98%	-$558K	﹤0.01%	7620
2024 Q1	$614K	Buy	16,900 +16,500	+4,125%	+$485K	﹤0.01%	3636
2023 Q4	$8K	Sell	400 -600	-60%	-$10K	﹤0.01%	7607
2023 Q3	$17K	Buy	+1,000	New	+$17.7K	﹤0.01%	6774
2022 Q4	–	Sell	-800	Closed	-$13K	–	10407
2022 Q3	$13K	Hold	800	–	–	﹤0.01%	8015
2022 Q2	$11K	Buy	+800	New	+$12K	﹤0.01%	8220

Other funds holding TARS

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Simplex Trading's TARS Position: Q1 2026 in Review

Simplex Trading reduced its Tarsus Pharmaceuticals (TARS) stake by 18% in Q1 2026, selling an estimated $38.3K and leaving 2,465 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #4471.

Simplex Trading first reported a position in TARS in Q2 2023 and has held it in 6 quarters since. The position peaked at $587K in Q1 2024. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

Simplex Trading held 2,465 shares of Tarsus Pharmaceuticals worth $173K as of Q1 2026.
Simplex Trading sold 548 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $38.3K.
Tarsus Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4471 holding.
Simplex Trading first reported a position in Tarsus Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
Simplex Trading's Tarsus Pharmaceuticals position peaked at $587K in Q1 2024.
253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.